Sign in
CompletedNo phase

The SPOT-HPV Study

Key facts

Who runs it
Dana-Farber Cancer Institute
Where
Boston, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
360 people enrolled
Started
30 Nov 2022
Ended
1 Jan 2026
Type of study
Observational, 2 groups
Treatments tested
  • Salivary TTMV-HPV DNA Test
  • Blood TTMV-HPV DNA Test
Record updated
21 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age 18+ years
  • Able to provide informed consent
  • Either one of the following:; Control cohort: Male individuals WITHOUT head and neck tumors that are, or may be, HPV-positive; Case cohort: Any individual WITH incident, untreated HPV-positive oropharynx squamous cell carcinoma

Who cannot take part

  • Unable to provide informed consent
  • Head and neck tumors of non-oropharynx subsites that are or may be HPV-positive, including oral cavity, sinonasal, laryngeal, hypopharyngeal, or nasopharyngeal squamous cell carcinomas

Where in United States

  • Brigham & Woman's HospitalBoston, United States
  • Dana-Farber Cancer InstituteBoston, United States

About the trial

What the trial wants to find out

The purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').

The 2 groups in the trial

  • Control Cohort: Adult Male Without HPV-positive throat cancer

    Participants will receive 1x Salivary TTMV-HPV DNA Test. If test is negative there will not be follow up, if test is positive participants will have repeat Salivary TTMV-HPV DNA Test, a blood test and head and neck exam.

    Treatment: Salivary TTMV-HPV DNA Test and Blood TTMV-HPV DNA Test

  • Case Cohort: Any Adult With HPV-positive throat cancer

    Participants will receive 1x Salivary and Blood TTMV-HPV DNA Test(s).

    Treatment: Salivary TTMV-HPV DNA Test

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterizing the Specificity and Sensitivity of Oral TTMV-HPV DNA Testing: The SPOT-HPV Study
Record updated
21 January 2026